Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice.
Cristina Villanueva-BuenoElena Montecatine-AlonsoFrancisco Jiménez-ParrillaMaría González-LópezSilvia Manrique-RodríguezFrancisco Moreno-RamosCarme Cañete-RamírezElisenda DolzAna García-RoblesJosé Manuel Caro-TellerMaría Teresa Moral-PumaregaElena Bergon-SendinMaría Teresa Gómez-Trevecedo CalvoCarmen Gallego-FernándezConcepción Álvarez Del Vayo-BenitoMarta Mejías-TruebaMaría Victoria Gil-Navarronull Paediatric Antimicrobial Defined Daily Dose Study Group KiDDDsPublished in: Antibiotics (Basel, Switzerland) (2023)
DDD validation has been achieved for the majority of intravenously administered antimicrobials used in clinical practice in the neonatal population. This will make it possible to have an indicator that will be used globally to estimate the consumption of antimicrobials in this population, thus confirming its usefulness and applicability.